356 related articles for article (PubMed ID: 31353223)
1. Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.
Nagashima H; Mahlakõiv T; Shih HY; Davis FP; Meylan F; Huang Y; Harrison OJ; Yao C; Mikami Y; Urban JF; Caron KM; Belkaid Y; Kanno Y; Artis D; O'Shea JJ
Immunity; 2019 Oct; 51(4):682-695.e6. PubMed ID: 31353223
[TBL] [Abstract][Full Text] [Related]
2. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.
Klose CSN; Mahlakõiv T; Moeller JB; Rankin LC; Flamar AL; Kabata H; Monticelli LA; Moriyama S; Putzel GG; Rakhilin N; Shen X; Kostenis E; König GM; Senda T; Carpenter D; Farber DL; Artis D
Nature; 2017 Sep; 549(7671):282-286. PubMed ID: 28869965
[TBL] [Abstract][Full Text] [Related]
3. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
[TBL] [Abstract][Full Text] [Related]
4. The Prostaglandin D
Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
[TBL] [Abstract][Full Text] [Related]
5. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.
Wallrapp A; Riesenfeld SJ; Burkett PR; Abdulnour RE; Nyman J; Dionne D; Hofree M; Cuoco MS; Rodman C; Farouq D; Haas BJ; Tickle TL; Trombetta JJ; Baral P; Klose CSN; Mahlakõiv T; Artis D; Rozenblatt-Rosen O; Chiu IM; Levy BD; Kowalczyk MS; Regev A; Kuchroo VK
Nature; 2017 Sep; 549(7672):351-356. PubMed ID: 28902842
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between ILC2s and Th2 cells varies among mouse models.
Gurram RK; Wei D; Yu Q; Butcher MJ; Chen X; Cui K; Hu G; Zheng M; Zhu X; Oh J; Sun B; Urban JF; Zhao K; Leonard WJ; Zhu J
Cell Rep; 2023 Feb; 42(2):112073. PubMed ID: 36735533
[TBL] [Abstract][Full Text] [Related]
7. IL-17A both initiates, via IFNγ suppression, and limits the pulmonary type-2 immune response to nematode infection.
Ajendra J; Chenery AL; Parkinson JE; Chan BHK; Pearson S; Colombo SAP; Boon L; Grencis RK; Sutherland TE; Allen JE
Mucosal Immunol; 2020 Nov; 13(6):958-968. PubMed ID: 32636457
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces.
Tsou AM; Yano H; Parkhurst CN; Mahlakõiv T; Chu C; Zhang W; He Z; Jarick KJ; Zhong C; Putzel GG; Hatazaki M; ; Lorenz IC; Andrew D; Balderes P; Klose CSN; Lira SA; Artis D
Nature; 2022 Nov; 611(7937):787-793. PubMed ID: 36323781
[TBL] [Abstract][Full Text] [Related]
9. SLAM-family receptors promote resolution of ILC2-mediated inflammation.
Wang Y; Quan Y; He J; Chen S; Dong Z
Nat Commun; 2024 Jun; 15(1):5056. PubMed ID: 38871792
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation.
Molofsky AB; Van Gool F; Liang HE; Van Dyken SJ; Nussbaum JC; Lee J; Bluestone JA; Locksley RM
Immunity; 2015 Jul; 43(1):161-74. PubMed ID: 26092469
[TBL] [Abstract][Full Text] [Related]
11. Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells.
Halim TYF; Rana BMJ; Walker JA; Kerscher B; Knolle MD; Jolin HE; Serrao EM; Haim-Vilmovsky L; Teichmann SA; Rodewald HR; Botto M; Vyse TJ; Fallon PG; Li Z; Withers DR; McKenzie ANJ
Immunity; 2018 Jun; 48(6):1195-1207.e6. PubMed ID: 29907525
[TBL] [Abstract][Full Text] [Related]
12. Alcohol-mediated susceptibility to lung fibrosis is associated with group 2 innate lymphoid cells in mice.
Chen L; Sun R; Lei C; Xu Z; Song Y; Deng Z
Front Immunol; 2023; 14():1178498. PubMed ID: 37457733
[TBL] [Abstract][Full Text] [Related]
13. Cutting Edge: CCR8 Signaling Regulates IL-25- and IL-33-Responsive Skin Group 2 Innate Lymphoid Cell Migration and Function.
Sun Z; Sen H; Zhu X; Islam SA
J Immunol; 2023 Dec; 211(12):1751-1755. PubMed ID: 37921466
[TBL] [Abstract][Full Text] [Related]
14. ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung.
Schuijs MJ; Png S; Richard AC; Tsyben A; Hamm G; Stockis J; Garcia C; Pinaud S; Nicholls A; Ros XR; Su J; Eldridge MD; Riedel A; Serrao EM; Rodewald HR; Mack M; Shields JD; Cohen ES; McKenzie ANJ; Goodwin RJA; Brindle KM; Marioni JC; Halim TYF
Nat Immunol; 2020 Sep; 21(9):998-1009. PubMed ID: 32747815
[TBL] [Abstract][Full Text] [Related]
15. Mapping Rora expression in resting and activated CD4+ T cells.
Haim-Vilmovsky L; Henriksson J; Walker JA; Miao Z; Natan E; Kar G; Clare S; Barlow JL; Charidemou E; Mamanova L; Chen X; Proserpio V; Pramanik J; Woodhouse S; Protasio AV; Efremova M; Griffin JL; Berriman M; Dougan G; Fisher J; Marioni JC; McKenzie ANJ; Teichmann SA
PLoS One; 2021; 16(5):e0251233. PubMed ID: 34003838
[TBL] [Abstract][Full Text] [Related]
16. [CGRP inhibits proliferation, activation and cytokine secretion of group 2 innate lymphoid cells (ILC2) in peripheral blood from patients with allergic rhinitis].
Zhuo H; Qi X; Xu N; Wang Y; An Y; Xue J; Zhao C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1094-1099. PubMed ID: 38140869
[TBL] [Abstract][Full Text] [Related]
17. SLC7A8 is a key amino acids supplier for the metabolic programs that sustain homeostasis and activation of type 2 innate lymphoid cells.
Panda SK; Kim DH; Desai P; Rodrigues PF; Sudan R; Gilfillan S; Cella M; Van Dyken SJ; Colonna M
Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2215528119. PubMed ID: 36343258
[TBL] [Abstract][Full Text] [Related]
18. In Situ Maturation and Tissue Adaptation of Type 2 Innate Lymphoid Cell Progenitors.
Zeis P; Lian M; Fan X; Herman JS; Hernandez DC; Gentek R; Elias S; Symowski C; Knöpper K; Peltokangas N; Friedrich C; Doucet-Ladeveze R; Kabat AM; Locksley RM; Voehringer D; Bajenoff M; Rudensky AY; Romagnani C; Grün D; Gasteiger G
Immunity; 2020 Oct; 53(4):775-792.e9. PubMed ID: 33002412
[TBL] [Abstract][Full Text] [Related]
19. Regulatory ILC2-Role of IL-10 Producing ILC2 in Asthma.
Emami Fard N; Xiao M; Sehmi R
Cells; 2023 Oct; 12(21):. PubMed ID: 37947634
[TBL] [Abstract][Full Text] [Related]
20. Alternative activation generates IL-10 producing type 2 innate lymphoid cells.
Seehus CR; Kadavallore A; Torre B; Yeckes AR; Wang Y; Tang J; Kaye J
Nat Commun; 2017 Dec; 8(1):1900. PubMed ID: 29196657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
